137.15 USD
-1.86 (-1.34%)
137.15 USD
0 (0%)
We assign a fundamental rating of 6 out of 10 to NHC. NHC was compared to 102 industry peers in the Health Care Providers & Services industry. NHC has an excellent profitability rating, but there are some minor concerns on its financial health. NHC has a valuation in line with the averages, but on the other hand it scores bad on growth. Finally NHC also has an excellent dividend rating. These ratings would make NHC suitable for dividend investing!
1. Profitability
1.1 Basic Checks
- In the past year NHC was profitable.
- In the past year NHC had a positive cash flow from operations.
- NHC had positive earnings in each of the past 5 years.
- Each year in the past 5 years NHC had a positive operating cash flow.
1.2 Ratios
- NHC has a better Return On Assets (6.71%) than 87.25% of its industry peers.
- With a decent Return On Equity value of 10.26%, NHC is doing good in the industry, outperforming 74.51% of the companies in the same industry.
- NHC has a Return On Invested Capital of 6.69%. This is in the better half of the industry: NHC outperforms 65.69% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for NHC is significantly below the industry average of 9.21%.
- The 3 year average ROIC (3.68%) for NHC is below the current ROIC(6.69%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.71% | ||
| ROE | 10.26% | ||
| ROIC | 6.69% |
ROA(3y)4.51%
ROA(5y)5.3%
ROE(3y)6.77%
ROE(5y)8.19%
ROIC(3y)3.68%
ROIC(5y)4.6%
1.3 Margins
- NHC has a Profit Margin of 7.19%. This is amongst the best in the industry. NHC outperforms 87.25% of its industry peers.
- NHC's Profit Margin has improved in the last couple of years.
- Looking at the Operating Margin, with a value of 7.99%, NHC is in the better half of the industry, outperforming 75.49% of the companies in the same industry.
- NHC's Operating Margin has improved in the last couple of years.
- NHC's Gross Margin of 38.11% is fine compared to the rest of the industry. NHC outperforms 67.65% of its industry peers.
- NHC's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.99% | ||
| PM (TTM) | 7.19% | ||
| GM | 38.11% |
OM growth 3Y-3.24%
OM growth 5Y5.6%
PM growth 3Y-15.45%
PM growth 5Y2.63%
GM growth 3Y-3.62%
GM growth 5Y-1.28%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NHC is destroying value.
- NHC has more shares outstanding than it did 1 year ago.
- The number of shares outstanding for NHC has been increased compared to 5 years ago.
- NHC has a worse debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 4.40 indicates that NHC is not in any danger for bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 4.40, NHC is in the better half of the industry, outperforming 79.41% of the companies in the same industry.
- NHC has a debt to FCF ratio of 0.93. This is a very positive value and a sign of high solvency as it would only need 0.93 years to pay back of all of its debts.
- NHC has a better Debt to FCF ratio (0.93) than 90.20% of its industry peers.
- NHC has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
- NHC's Debt to Equity ratio of 0.10 is fine compared to the rest of the industry. NHC outperforms 75.49% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | 0.93 | ||
| Altman-Z | 4.4 |
ROIC/WACC0.75
WACC8.86%
2.3 Liquidity
- NHC has a Current Ratio of 1.72. This is a normal value and indicates that NHC is financially healthy and should not expect problems in meeting its short term obligations.
- The Current ratio of NHC (1.72) is better than 69.61% of its industry peers.
- A Quick Ratio of 1.69 indicates that NHC should not have too much problems paying its short term obligations.
- NHC has a Quick ratio of 1.69. This is in the better half of the industry: NHC outperforms 71.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.72 | ||
| Quick Ratio | 1.69 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an nice 13.19% over the past year.
- Measured over the past years, NHC shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.03% on average per year.
- NHC shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.82%.
- NHC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.58% yearly.
EPS 1Y (TTM)13.19%
EPS 3Y-10.09%
EPS 5Y8.03%
EPS Q2Q%-11.88%
Revenue 1Y (TTM)22.82%
Revenue growth 3Y6.76%
Revenue growth 5Y5.58%
Sales Q2Q%24.7%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 20.44 indicates a rather expensive valuation of NHC.
- NHC's Price/Earnings ratio is a bit cheaper when compared to the industry. NHC is cheaper than 70.59% of the companies in the same industry.
- The average S&P500 Price/Earnings ratio is at 27.38. NHC is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.44 | ||
| Fwd PE | N/A |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, NHC is valued a bit cheaper than the industry average as 68.63% of the companies are valued more expensively.
- Based on the Price/Free Cash Flow ratio, NHC is valued a bit cheaper than the industry average as 69.61% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.9 | ||
| EV/EBITDA | 11.42 |
4.3 Compensation for Growth
- The excellent profitability rating of NHC may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.55
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
- NHC has a Yearly Dividend Yield of 1.84%.
- NHC's Dividend Yield is rather good when compared to the industry average which is at 0.59. NHC pays more dividend than 92.16% of the companies in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.85, NHC has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.84% |
5.2 History
- The dividend of NHC has a limited annual growth rate of 3.30%.
- NHC has paid a dividend for at least 10 years, which is a reliable track record.
- NHC has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)3.3%
Div Incr Years11
Div Non Decr Years11
5.3 Sustainability
- NHC pays out 35.96% of its income as dividend. This is a sustainable payout ratio.
- NHC's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP35.96%
EPS Next 2YN/A
EPS Next 3YN/A
137.15
-1.86 (-1.34%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-31 2025-10-31
Earnings (Next)02-25 2026-02-25
Inst Owners62.44%
Inst Owner Change0.14%
Ins Owners7.07%
Ins Owner Change-0.09%
Market Cap2.13B
Revenue(TTM)1.46B
Net Income(TTM)104.80M
Analysts60
Price TargetN/A
Short Float %2.59%
Short Ratio4.36
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.84% |
Yearly Dividend2.4
Dividend Growth(5Y)3.3%
DP35.96%
Div Incr Years11
Div Non Decr Years11
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.44 | ||
| Fwd PE | N/A | ||
| P/S | 1.46 | ||
| P/FCF | 17.9 | ||
| P/OCF | 14.28 | ||
| P/B | 2.08 | ||
| P/tB | 2.56 | ||
| EV/EBITDA | 11.42 |
EPS(TTM)6.71
EY4.89%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)7.66
FCFY5.59%
OCF(TTM)9.61
OCFY7%
SpS93.95
BVpS65.84
TBVpS53.58
PEG (NY)N/A
PEG (5Y)2.55
Graham Number99.7
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.71% | ||
| ROE | 10.26% | ||
| ROCE | 9.01% | ||
| ROIC | 6.69% | ||
| ROICexc | 8.35% | ||
| ROICexgc | 10.23% | ||
| OM | 7.99% | ||
| PM (TTM) | 7.19% | ||
| GM | 38.11% | ||
| FCFM | 8.16% |
ROA(3y)4.51%
ROA(5y)5.3%
ROE(3y)6.77%
ROE(5y)8.19%
ROIC(3y)3.68%
ROIC(5y)4.6%
ROICexc(3y)4.49%
ROICexc(5y)5.97%
ROICexgc(3y)5.54%
ROICexgc(5y)6.99%
ROCE(3y)4.96%
ROCE(5y)6.21%
ROICexgc growth 3Y-4%
ROICexgc growth 5Y11.11%
ROICexc growth 3Y-3.17%
ROICexc growth 5Y7.37%
OM growth 3Y-3.24%
OM growth 5Y5.6%
PM growth 3Y-15.45%
PM growth 5Y2.63%
GM growth 3Y-3.62%
GM growth 5Y-1.28%
F-Score4
Asset Turnover0.93
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | 0.93 | ||
| Debt/EBITDA | 0.64 | ||
| Cap/Depr | 68.45% | ||
| Cap/Sales | 2.07% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 92.81% | ||
| Profit Quality | 113.47% | ||
| Current Ratio | 1.72 | ||
| Quick Ratio | 1.69 | ||
| Altman-Z | 4.4 |
F-Score4
WACC8.86%
ROIC/WACC0.75
Cap/Depr(3y)68.9%
Cap/Depr(5y)71.13%
Cap/Sales(3y)2.45%
Cap/Sales(5y)2.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.19%
EPS 3Y-10.09%
EPS 5Y8.03%
EPS Q2Q%-11.88%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)22.82%
Revenue growth 3Y6.76%
Revenue growth 5Y5.58%
Sales Q2Q%24.7%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y63.08%
EBIT growth 3Y3.3%
EBIT growth 5Y11.5%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y219.85%
FCF growth 3Y51.34%
FCF growth 5Y1.58%
OCF growth 1Y136.11%
OCF growth 3Y19.81%
OCF growth 5Y1.4%
NATIONAL HEALTHCARE CORP / NHC FAQ
What is the fundamental rating for NHC stock?
ChartMill assigns a fundamental rating of 6 / 10 to NHC.
Can you provide the valuation status for NATIONAL HEALTHCARE CORP?
ChartMill assigns a valuation rating of 4 / 10 to NATIONAL HEALTHCARE CORP (NHC). This can be considered as Fairly Valued.
How profitable is NATIONAL HEALTHCARE CORP (NHC) stock?
NATIONAL HEALTHCARE CORP (NHC) has a profitability rating of 8 / 10.
How sustainable is the dividend of NATIONAL HEALTHCARE CORP (NHC) stock?
The dividend rating of NATIONAL HEALTHCARE CORP (NHC) is 7 / 10 and the dividend payout ratio is 35.96%.